Australasian Dental Practice

Monday, 4 December, 2023

01 May 2009 | Australasian Dental Practice

news > Briefs > Page 8

GSK acquires biotene dry mouth products

GlaxoSmithKline Consumer Healthcare has acquired the complete range of biotène branded products indicated in the treatment of xerostomia (dry mouth) from privately held US company Laclede. Xerostomia is a significant health issue associated with chronic medical conditions that include diabetes, rheumatoid arthritis, Sjogren's syndrome and Parkinson's disease. Additionally, chemotherapy and radiation treatments together with more than 400 known medications have side-effects that can cause Dry Mouth. The products are also used by mouth breathers. The biotène system has been appropriately formulated to relieve dry mouths. Each product contains the biotène salivary LP3 enzyme system, is alcohol-free, sugar-free and sodium lauryl sulphate-free. biotène also contains moisturisers and lubricants to provide relief from the symptoms of dry mouth. The biotène range consists of toothpaste, mouthwash, gel, liquid, mouth-spray and chewing gum. The range provides both in-home hygiene products and out-of-home relief products for the dry mouth patient.

To purchase biotène products, dental practices should contact distributor Critical Dental.

Stream the latest dental videos...

Upcoming Events...

Dec 06 2023



Jan 08 2024
Feb 13 2024
Mar 12 2024
Mar 13 2024
Mar 21 2024

ADX24 Sydney


Apr 16 2024

Dentists Behaving 'Very' Badly


Apr 19 2024

IDEM Singapore 2024

Singapore, SINGAPORE

May 14 2024
May 24 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025